2021
Physician Incentive Compensation Plans in Academic Medical Centers: The Imperative to Prioritize Value
Coleman D, Joiner K. Physician Incentive Compensation Plans in Academic Medical Centers: The Imperative to Prioritize Value. The American Journal Of Medicine 2021, 134: 1344-1349. PMID: 34343514, DOI: 10.1016/j.amjmed.2021.06.040.Peer-Reviewed Original ResearchConceptsAcademic medical centerClinical volumeMedical CenterValue of careProspective assessmentClinical valueClinical practiceHealth outcomesPhysician compensation planClinical workforceClinical encountersPractice circumstancesHealth carePublic healthCareValid measureOutcomesKey outcomesCliniciansPhysicians
2018
Impact of an Interdisciplinary Computational Research Section in a Department of Medicine: An 8-Year Perspective
Spira A, Coleman D. Impact of an Interdisciplinary Computational Research Section in a Department of Medicine: An 8-Year Perspective. The American Journal Of Medicine 2018, 131: 846-851. PMID: 29601802, DOI: 10.1016/j.amjmed.2018.03.008.Peer-Reviewed Original ResearchIntegrating Social Determinants of Health Into Graduate Medical Education
Siegel J, Coleman DL, James T. Integrating Social Determinants of Health Into Graduate Medical Education. Academic Medicine 2018, 93: 159-162. PMID: 29140918, DOI: 10.1097/acm.0000000000002054.Peer-Reviewed Original ResearchConceptsGraduate Medical EducationMedical educationService-learning opportunitiesFaculty development programmingCurricular approachHidden curriculumClinical educationExperiential learningInterprofessional activitiesInvited CommentarySpecific competenciesClinical traineesDevelopment programmingEducationCurriculumCompetenciesKey principlesSocial determinantsTraineesHealth needsVital componentLearningMasteryAuthorsUniversalization
2017
Catalyzing Interdisciplinary Research and Training
Ravid K, Seta F, Center D, Waters G, Coleman D. Catalyzing Interdisciplinary Research and Training. Academic Medicine 2017, 92: 1399-1405. PMID: 28445220, DOI: 10.1097/acm.0000000000001716.Peer-Reviewed Original ResearchThrombotic Microangiopathy: A Multidisciplinary Team Approach
Gordon CE, Chitalia VC, Sloan JM, Salant DJ, Coleman DL, Quillen K, Ravid K, Francis JM. Thrombotic Microangiopathy: A Multidisciplinary Team Approach. American Journal Of Kidney Diseases 2017, 70: 715-721. PMID: 28720207, DOI: 10.1053/j.ajkd.2017.05.017.Peer-Reviewed Original ResearchConceptsThrombotic microangiopathyClinical carePathogenesis of TMAInitiation of therapyMicroangiopathic hemolytic anemiaPresence of microthrombiFront-line providersPrompt institutionOrgan dysfunctionClinical presentationClinical managementVariable presentationHemolytic anemiaLower incidenceMultidisciplinary teamClinical databaseMicrovascular bedMultiple specialtiesPoor awarenessTranslational researchInterdisciplinary teamPresentationCareClinical facultyLaboratory testingStrategies for Developing and Recognizing Faculty Working in Quality Improvement and Patient Safety
Coleman DL, Wardrop RM, Levinson WS, Zeidel ML, Parsons PE. Strategies for Developing and Recognizing Faculty Working in Quality Improvement and Patient Safety. Academic Medicine 2017, 92: 52-57. PMID: 27191838, DOI: 10.1097/acm.0000000000001230.Peer-Reviewed Original ResearchConceptsQI/PSChange managementContributions of facultyStrategic prioritiesAcademic clinical departmentsCollaborative networksMost academic departmentsProactive approachQuality improvementRigorous training programDecision makingImprovement activitiesArticle advocatesProfessional organizationsIndividual faculty membersQuality improvement activitiesAcademic departmentsManagementOpportunitiesLeadershipScholarly impactOrganizationComprehensive approachFaculty engagementResponsibility
2016
The Department of Medicine in 2030: A Look Ahead
Coleman DL, Johnson DH. The Department of Medicine in 2030: A Look Ahead. The American Journal Of Medicine 2016, 129: 1226-1233. PMID: 27480389, DOI: 10.1016/j.amjmed.2016.07.008.Peer-Reviewed Original ResearchConceptsClinical phenotypic informationOutcomes of careDepartment of MedicineEfficient clinical carePatient preferencesPatient satisfactionClinical careShortage of physiciansClinical programsHealth care transformationProficiency of traineesHealth careCareCare transformationDiverse funding sourcesPublic healthInterdisciplinary teamCliniciansChairs of departmentsDepartmentMedicineCurrent core competenciesEducational programsMembers of departments
2013
Promoting interdisciplinary research in departments of medicine: results from two models at Boston University School of Medicine.
Coleman DL, Spira A, Ravid K. Promoting interdisciplinary research in departments of medicine: results from two models at Boston University School of Medicine. Transactions Of The American Clinical And Climatological Association 2013, 124: 275-82. PMID: 23874035, PMCID: PMC3715902.Peer-Reviewed Original Research
2012
Perspective
Joiner KA, Coleman DL. Perspective. Academic Medicine 2012, 87: 230-235. PMID: 22273616, DOI: 10.1097/acm.0b013e31823faafb.Peer-Reviewed Original Research
2008
Establishing Policies for the Relationship Between Industry and Clinicians: Lessons Learned From Two Academic Health Centers
Coleman DL. Establishing Policies for the Relationship Between Industry and Clinicians: Lessons Learned From Two Academic Health Centers. Academic Medicine 2008, 83: 882-887. PMID: 18728449, DOI: 10.1097/acm.0b013e318181da0e.Peer-Reviewed Original Research
2006
Viewpoint:
Coleman DL. Viewpoint:. Academic Medicine 2006, 81: 728-731. PMID: 16868427, DOI: 10.1097/00001888-200608000-00009.Peer-Reviewed Original ResearchImproving Clinical Productivity in the Academic Setting: A Novel Incentive Plan Based on Utility Theory
Wilson MS, Joiner KA, Inzucchi SE, Mulligan GJ, Mechem MF, Gross CP, Coleman DL. Improving Clinical Productivity in the Academic Setting: A Novel Incentive Plan Based on Utility Theory. Academic Medicine 2006, 81: 306-316. PMID: 16565178, DOI: 10.1097/00001888-200604000-00003.Peer-Reviewed Original ResearchGuidelines for Interactions between Clinical Faculty and the Pharmaceutical Industry: One Medical School’s Approach
Coleman DL, Kazdin AE, Miller LA, Morrow JS, Udelsman R. Guidelines for Interactions between Clinical Faculty and the Pharmaceutical Industry: One Medical School’s Approach. Academic Medicine 2006, 81: 154-160. PMID: 16436576, DOI: 10.1097/00001888-200602000-00008.Peer-Reviewed Original Research
2003
Measuring Physicians' Productivity in a Veterans Affairs Medical Center
Coleman DL, Moran E, Serfilippi D, Mulinski P, Rosenthal R, Gordon B, Mogielnicki RP. Measuring Physicians' Productivity in a Veterans Affairs Medical Center. Academic Medicine 2003, 78: 682-689. PMID: 12857686, DOI: 10.1097/00001888-200307000-00007.Peer-Reviewed Original Research
1996
Identification of a Cellular Protein That Specifically Interacts with the Essential Cysteine Region of the HIV-1 Tat Transactivator
KAMINE J, ELANGOVAN B, SUBRAMANIAN T, COLEMAN D, CHINNADURAI G. Identification of a Cellular Protein That Specifically Interacts with the Essential Cysteine Region of the HIV-1 Tat Transactivator. Virology 1996, 216: 357-366. PMID: 8607265, DOI: 10.1006/viro.1996.0071.Peer-Reviewed Original ResearchMeSH KeywordsAcetyltransferasesAmino Acid SequenceBase SequenceCloning, MolecularConserved SequenceCysteineDNA, ComplementaryEscherichia coliGene Expression Regulation, ViralGene Products, tatHeLa CellsHistone AcetyltransferasesHIV-1HumansLysine Acetyltransferase 5Molecular Sequence DataPoint MutationPromoter Regions, GeneticProtein BindingProteinsSaccharomyces cerevisiaeTat Gene Products, Human Immunodeficiency VirusConceptsHIV gene expressionGene expressionN-terminal 31 amino acidsEssential cysteine residueFull-length cDNATat activation domainHIV-1 Tat transactivatorPartial cDNA cloneHIV-1 promoterActivation domainCellular proteinsTAT activityAbolishes interactionCysteine regionCDNA clonesCellular cofactorsCysteine residuesTransient expressionTat transactivationTat transactivatorHIV-1 TatAmino acidsInteractive cloningProteinPromoter
1992
Interleukin-6: An autocrine regulator of mesangial cell growth
Coleman D, Ruef C. Interleukin-6: An autocrine regulator of mesangial cell growth. Kidney International 1992, 41: 604-606. PMID: 1573836, DOI: 10.1038/ki.1992.91.Peer-Reviewed Original ResearchConceptsInterleukin-6Transgenic miceVivo studiesTransgenic mouse modelMesangial cell growthIL-6 geneGranulocyte-macrophage colonyIgG1 plasmacytosisCytokine productionImmune cellsMesangioproliferative glomerulonephritisInterleukin-1Autocrine regulatorMouse modelGlomerular cellsCell culture modelProliferative effectTarget cellsTissue distributionImmunoglobulin heavy chain enhancerChain enhancerTissue cellsCulture modelMiceNontransformed cell types
1991
Conversion of a human B cell lymphoma line by Epstein-Barr virus is associated with increased tyrosine phosphorylation of a 50 kilodalton cytosolic protein
Lacy J, Bartiss A, Coleman D. Conversion of a human B cell lymphoma line by Epstein-Barr virus is associated with increased tyrosine phosphorylation of a 50 kilodalton cytosolic protein. Virus Research 1991, 20: 85-96. PMID: 1656626, DOI: 10.1016/0168-1702(91)90063-2.Peer-Reviewed Original ResearchConceptsEpstein-Barr virusB cellsHuman B cellsB-cell lymphoma linePresence of EBVLymphoma linesProtein tyrosine phosphorylationEBV infectionHuman B cell lymphoma lineTyrosine phosphorylationB lymphocytesImmortalized lymphoblastoid cellsBiochemical changesLymphoblastoid cellsInfectionEndogenous tyrosine kinasesContinuous proliferationCytosolic proteinsTyrosine kinaseVirusCellsPhosphorylationPhosphotyrosine antibodiesLymphocytesProtein
1990
Macrophage colony-stimulating factor production by murine and human keratinocytes. Enhancement by bacterial lipopolysaccharide.
Chodakewitz J, Lacy J, Edwards S, Birchall N, Coleman D. Macrophage colony-stimulating factor production by murine and human keratinocytes. Enhancement by bacterial lipopolysaccharide. The Journal Of Immunology 1990, 144: 2190-6. PMID: 2179407, DOI: 10.4049/jimmunol.144.6.2190.Peer-Reviewed Original Research
1989
Rat mesangial cells produce granulocyte-macrophage colony-stimulating factor
Budde K, Coleman D, Lacy J, Sterzel R. Rat mesangial cells produce granulocyte-macrophage colony-stimulating factor. American Journal Of Physiology 1989, 257: f1065-f1078. PMID: 2690641, DOI: 10.1152/ajprenal.1989.257.6.f1065.Peer-Reviewed Original ResearchConceptsRat mesangial cellsGranulocyte-macrophage colony-stimulating factorCultured rat mesangial cellsMesangial cellsColony-stimulating factorGM-CSFMC-CMGlomerular mesangial cellsPeritoneal MPsEffector cellsIL-2Inflammatory processGlomerular diseaseInterleukin-2T cellsT lymphocytesInterleukin-4Murine GM-CSFRenal glomeruliSerum-free conditionsSoluble factorsProliferative activitySpecific cDNA probesGM-CSF mRNA transcriptsPresent findings
1988
Hematopoietic, Lymphopoietic, and Proinflammatory Cytokines Produced by Human and Murine Keratinocytes
KUPPER T, HOROWITZ M, BIRCHALL N, MIZUTANI H, COLEMAN D, McGUIRE J, FLOOD P, DOWER S, LEE F. Hematopoietic, Lymphopoietic, and Proinflammatory Cytokines Produced by Human and Murine Keratinocytes. Annals Of The New York Academy Of Sciences 1988, 548: 262-270. PMID: 2470299, DOI: 10.1111/j.1749-6632.1988.tb18814.x.Peer-Reviewed Original Research